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There is a growing concern for the possible health impact of nanoparticles. The main objective of this study was to investigate the
allergy-promoting capacity of four different carbon nanofiber (CNF) samples in an injection and an airwaymousemodel of allergy.
Secondly, the potency of the CNFwas compared to the previously reported allergy-promoting capacity of carbon nanotubes (CNT)
in the airway model. Ultrafine carbon black particles (ufCBP) were used as a positive control. Particles were given together with
the allergen ovalbumin (OVA) either by subcutaneous injection into the footpad or intranasally to BALB/cA mice. After allergen
booster, OVA-specific IgE, IgG1, and IgG2a in serum were measured. In the airway model, inflammation was determined as influx
of inflammatory cells (eosinophils, neutrophils, lymphocytes, and macrophages) and by mediators (MCP-1 and TNF-𝛼 present in
bronchoalveolar fluid (BALF)). CNF and CNT both increased OVA-specific IgE levels in the two models, but in the airway model,
the CNT gave a significantly stronger IgE response than the CNF. Furthermore, the CNT and not the CNF promoted eosinophil
lung inflammation. Our data therefore suggest that nanotube-associated properties are particularly potent in promoting allergic
responses.
1. Introduction
Allergic airway diseases are characterized by eosinophil and
lymphocyte lung inflammation, as well as allergen-specific
IgE in serum. Ultrafine particles present in ambient air have,
in animalmodels and in humans, been demonstrated tomod-
ulate airway inflammations and promote allergic responses in
the lung [1–4]. Carbon nanotubes (CNT) are particles applied
in an increasing number of consumer products and are also
incidental components in indoor air pollution [5, 6]. Carbon
nanofibers (CNF) are useful inmany of the same applications
asCNT, such as Li-ion batteries and polymer nanocomposites
[7]. In parallel to the increasing manufacture of CNT and
CNF, there is a growing concern for the health impact of
these nanoparticles in occupational workers and consumers
in general, also in relation to allergy. Inhalation studies
in rodents suggest that CNT may induce toxic effects like
transient inflammation, fibrosis, and granuloma formation
[8], and mice with a preexisting allergic inflammation have
been reported to be particularly susceptible [9]. Further,
single-walled (sw) and multiwalled (mw) CNT have been
reported to increase allergen-specific IgE levels, eosinophil
airway inflammation, andTh2-associated cytokine responses
in mice models [2, 10, 11]. In support, Park and coworkers
demonstrated increased total IgE, Th2-associated cytokine,
and B cell levels in mice after a single intratracheal exposure
to mwCNT [12]. However, little is known about the charac-
teristics of CNT responsible for the allergy-promoting effect.
The possible allergy-promoting properties of CNF have not
been investigated.
The main objective of this study was to investigate the
allergy-promoting capacity of four different CNF samples
in an injection and an airway mouse model of allergy.
Secondly, the potency of the CNF was compared to the
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previously reported allergy-promoting capacity of CNT and
ultrafine carbon black particles (ufCBP) in the airwaymodel.
Knowledge on which physicochemical characteristics of the
particles are important for their biological effects is essential
to enable manufacturing of particles with low toxicity. We,
therefore, explored the importance of major physicochemical
properties of carbon nanoparticles on their capacity to mod-
ulate allergy, by comparing the allergy-promoting capacity
of samples having different physicochemical properties. Four
samples of well-characterized, qualitatively different CNF
produced in the same pilot plant were tested in both mouse
models (CNF A, B, C, and D [7]). By deliberate use of
different conditions and purification steps during the CNF
manufacturing process, four samples with different particle
properties such as fiber width and length, open versus
closed channels, metal impurity content, relative surface
area, presence of structural defects, and relative amount of
fibers to other graphitic material were produced. Samples of
swCNT, mwCNT, and “spherical” ufCBP (Printex90), previ-
ously shown to promote allergic responses in the two mouse
models used [2], were also included in the airway model.
The allergy parameters allergen-specific IgE levels in serum
and eosinophil lung inflammation were measured. Allergen-
specific IgG2a antibodies and the presence of inflammatory
cells, MCP-1, and TNF-𝛼 in bronchoalveolar lavage fluid
(BALF) were also determined, to reflect Th1- and general
inflammatory responses.
2. Material and Methods
2.1. Animals. Female inbred BALB/cAnNCrl mice (Charles
River, Sulzfeld, Germany) were 6-7 weeks old upon arrival
and were acclimatised for one week. Four animals were
housed per cage in Innorack IVC (Innovive Inc., CA, USA),
containing Nestpaks filled with aspen 4HK bedding (Date-
sand Ltd, Manchester, UK). The mice were exposed to a
12 hr/12 hr light/dark cycle (30–60 lux in cages), regulated
room temperature (20 ± 2∘C), and 40–60% relative humidity.
Pelleted food (RM1, SDS, Essex, UK) and tap water were
provided ad libitum. The experiments were performed in
conformity with the laws and regulations for experiments
with live animals in Norway and were approved by the
Norwegian Experimental Animal Board under the Ministry
of Agriculture (FOTS ID numbers 678 and 1005).
2.2. Particle Source and Characteristics. Four qualitatively
different batches of carbon nanofibers (CNF A, B, C and
D) were kindly provided by Statoil and Elkem Carbon AS
(Kristiansand, Norway). The particles were produced from
natural gas in a catalytic chemical vapor deposition (CVD)
process and processed as reported [11]. The swCNT and
mwCNT, also produced byCVDmethod, were obtained from
Sigma-Aldrich (St. Louis, MO, USA, Cat. numbers 636797
and 636487, resp.). Ultrafine carbon black particles (ufCBP,
Printex90), kindly provided by Degussa (Ko¨ln, Germany),
were included as a positive reference particle for adjuvant
activity in mice [1, 2]. All particle samples were characterized
by transmission electronmicroscopy (TEM), and the specific
surface areawas determined by nitrogen adsorption using the
Brunauer, Emmet, and Teller method (BET). The endotoxin
levelswere determined in particle supernatants by the limulus
amebocyte lysate (LAL) assay as previously described [2,
7], and the pH of the particle supernatants was measured
(Mettler Toledo AS, NY, USA).
2.3. Particle and Allergen Preparations. Ovalbumin (OVA,
Gal d1; chicken egg albumin, grade VII, Sigma, St. Louis,
MO, USA) was used as allergen after removal of endotoxin
by Detoxi-Gel Endotoxin Removing Gel (Pierce, Rockford,
IL, USA). The final endotoxin level measured less than
0.025 ng/mg OVA, as determined by the LAL assay. Particle
suspensions were prepared in Hank’s balanced salt solution
(HBSS), with BALB/cA mouse serum to facilitate suspension
of particles, and microtip probe sonicated as described in
Nygaard et al. [2]. The CNT and CNF were even then mainly
observed as agglomerates in TEM.
2.4. Injection Model. The IgE adjuvant capacity of the CNF
particles was initially investigated in a footpad injection
model suitable for studying respiratory allergy adjuvants
(method reviewed in [13], performed as described in [2]).
In short, groups of eight mice were given a single dose of
200𝜇g of CNFA, B, C, D, or ufCBP together with 10𝜇g OVA,
OVA boosted (10 𝜇g) after 21 days and terminated on day 26.
Sera were collected and stored at −20∘C until quantification
ofOVA-specific IgE, IgG1, and IgG2a by ELISA (see below). A
particle dose of 200𝜇g was chosen, a dose previously shown
to give a pronounced adjuvant effect of CNT in this injection
model [2].
2.5. Intranasal Model. The adjuvant capacity of the particles
after airway exposure was examined in an intranasal mouse
model. Exposures were performed as described in [2], and
a particle dose previously giving pronounced effects of CNT
in the intranasal model was chosen [2]. In short, 133.3𝜇g
CNF A, B, C, D, swCNT, mwCNT, or ufCBP together with
10 𝜇g OVA was given intranasally to groups of ten mice on
three consecutive days, giving a total dose of 400 𝜇g particles
and 30 𝜇g OVA during sensitization. All mice were OVA-
boosted intranasally (10 𝜇g per day) on days 21, 22, and
23. On day 26, the animals were deeply anesthetized by a
0.3mL intraperitoneal injection of a mixture of Zoletil forte
(17mg/kg tiletamine and 17mg/kg zolazepam; Virbac Inter-
national, Carros Cedex, France) and Narcoxyl (13.6mg/kg
xylazine; Intervet/Schering-PloughAnimalHealth, Boxmeer,
The Netherlands). Sera were stored at −20∘C until quan-
tification of OVA-specific IgE, IgG1, and IgG2a by ELISA
(see below). Lung inflammation was determined by total
and differential cell counts and cytokine levels in BALF (see
below). Based on previous findings with sw andmwCNT [2],
the cytokines TNF-𝛼 and MCP-1 in BALF were selected.
2.6. Detection of IgE, IgG1, and IgG2a Anti-OVA Antibodies.
Detection of OVA-specific IgE, IgG1, and IgG2a antibodies
was performed by ELISAs as described in Nygaard et al.
[2]. The sera to be tested were diluted 1 : 10 for IgE and
IgG2a, and for IgG1 diluted 1 : 4 000 and 1 : 20 000 for the
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injection and intranasal models, respectively. Values outside
the dynamic range of the standard curve were set to a value
just below/above the detection limit.
2.7. BALF Collection, Preparation, and Analyses. BALF was
collected and prepared, and total and differential cell counts
were determined as previously described [2, 14]. In short,
the supernatant from a first lavage was stored at −80∘C
until cytokine measurements, while the cells from all three
lavages were pooled, counted, and stained, and 400 cells
per slide were differentiated into neutrophils, eosinophils,
epithelial cells, lymphocytes, and macrophages. A number
of macrophages appeared to contain particles, but since we
could not determine whether the particles were taken up or
were adsorbed to the cell membranes, they were counted as
particle-associated macrophages. In BALF supernatants, the
levels of tumor necrosis factor-alpha (TNF-𝛼) and monocyte
chemoattractant protein-1 (MCP-1) were determined using
BD Cytometric Bead Array (CBA) Mouse Soluble Protein
Flex Sets, as previously described [2].
2.8. Data Analysis. The data were log10-transformed to meet
the assumptions for running one-way ANOVAs. In order
to determine which groups differed significantly from the
others when the ANOVAs were positive (𝑃 ≤ 0.05), pairwise
comparisons were performed by Tukey’s post hoc test. Group
differences were considered statistically significant if 𝑃 ≤
0.05. All statistical analyses were performed with SigmaStat
Statistical Analysis System for Windows Version 2.03 (Jandel
Scientific, Erkrath, Germany).
3. Results
3.1. Particle Characterization. Particle sample properties are
shown in Table 1, while the methods used for particle char-
acterization and more comprehensive characterization of the
samples are previously reported [2, 7]. TEM micrographs
at similar magnifications from CNF A, B, C, D, swCNT,
and mwCNT samples are presented in Figures 1(a)–1(f),
respectively. Systematic inspection of the TEM micrographs
revealed that the majority of the CNF agglomerates were
within the size range 0.6𝜇m to 2.6 𝜇m. The CNF were wider
than the CNT, and the mwCNT were wider than the swCNT,
as illustrated in the micrographs and given by the mean fiber
width presented in Table 1.Most CNF are fractured or broken
and therefore, on an average, are shorter than the CNT (as
illustrated by dotted arrows in Figure 1, Table 1). Inspection of
the TEMmicrographs also showed that CNF samples and the
swCNT sample contain disordered graphitic material, while
the mwCNT sample is more homogeneous. High numbers
of metal particles were observed in CNF A, CNF C, and
swCNT, mainly embedded in the carbon material (indicated
by arrows in Figures 1(c), 1(e), and 1(f)). CNF A and CNF C
have a higher surface area, a lower mean fiber diameter, and
a higher presence of structural defects than CNF B and CNF
D samples (Table 1).
Figure 2 shows the typical internal structure of CNF
and CNT in high-resolution TEM images. The CNT con-
sist of single or multiple concentric graphene sheets rolled
into form of cylinders (Figures 2(c) and 2(d)). In contrast,
the CNF were classified into two main types of stacked
arrangements of graphite cones: with channels that aremostly
open (Figure 2(a)) or with periodically closed channels
(Figure 2(b)).The latter are also characterized by closed layers
on the CNF surface, as indicated by arrows. Although the
open channel type was found in all CNF samples, only the
CNF B and CNF D samples contained a high fraction of the
periodically closed channel type. As previously reported [2],
only half of the tubes in the swCNT sample were identified as
single-walled, the other half being multiwalled. Most tubes
in the mwCNT sample were defective, as exemplified in
Figure 2(d) (arrowhead).
The particles were also studied after preparation in the
medium used for the in vivo studies. As judged by TEM
analyses, the sonication process did not affect the length of
the CNT, whereas some breakage of the CNF was observed
(data not shown). This was most probably due to a lower
mechanical strength of the fibers compared to the tubes,
caused by the different stacking of the graphite layers. The
acidity (pH) of the particle supernatants did not differ
markedly between the particles, and the endotoxin levelswere
below detection limit for all particles, except swCNT which
had a detectable but low level (Table 1).
3.2. OVA-Specific IgE, IgG1, and IgG2a Levels in Serum
after Coinjection of Particles and OVA in the Footpad. In
the footpad injection model, OVA-specific IgE levels were
statistically significantly higher inmice treatedwithOVA and
CNFA, CNFC, or ufCBP thanwithOVA alone (Figure 3(a)).
ufCBP elicited significantly higher IgE levels than CNF B
and CNF D, and CNF A elicited significantly higher levels
than CNF D. OVA-specific IgG1 levels were significantly
elevated by all particles, but CNF A and CNF C had higher
IgG1-adjuvant activity than CNF B and D, but statistically
significant only for CNFD (Figure 3(b)). CNFA, CNFC, and
ufCBP gave weakly but significantly elevated levels of OVA-
specific IgG2a levels (Figure 3(c)).
3.3. OVA-Specific IgE, IgG1, and IgG2a Levels in Serum after
Intranasal Coexposure to Particles and OVA. In the intranasal
model, all particles significantly increased OVA-specific IgE
levels compared to the OVA control group (Figure 4(a)).
The four CNF samples and ufCBP elicited similar levels
of IgE, while in comparison, the sw and mw CNT elicited
very high IgE levels. Also the OVA-specific IgG1 levels
were significantly increased by all particles, and mwCNT
elicited significantly higher levels than CNF A and CNF
B (Figure 4(b)). As compared to the OVA control group,
OVA-specific IgG2a levels were significantly increased after
exposure to CNF C and mwCNT and also tended to be
increased by swCNT (𝑃 = 0.079) and ufCBP exposure (𝑃 =
0.088; Figure 4(c)).
3.4. Airway Inflammation after Intranasal Coexposure to
Particles and OVA. In the intranasally exposed mice, CNF B,
CNF C, sw and mw CNT, and ufCBP with OVA significantly
increased the total number of BALF cells, compared to the
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(a) (b)
(c) (d)
(e) (f)
Figure 1: TEMmicrographs of the particle samples. Micrographs of CNF A (a), CNF B (b), CNF C (c), CNF D (d), swCNT (e), and mwCNT
(f) illustrate the difference in width and length between the CNF and CNT. Examples of metallic particle presence are indicated by dense
arrows. Most metallic particles are embedded in the carbon material. Shorter fragments of fibers are indicated by dotted arrows.
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(a) Open-channel CNF (b) Periodically closed CNF
(c) swCNT (d) mwCNT
Figure 2:High-resolution images of particles, illustrating their internal structure.TheherringboneCNFs consisted of graphite layers arranged
at an angle to the axis of the filament structure ((a), (b)).Themicrographs show the structure of a typical open-channel fiber found in all CNF
samples (a) and a periodically closed fiber present in large amounts only in CNF B and CNF D (b). Many graphite layers in the periodically-
closed type of fiber have closed ends at the surface, indicated by arrows in (b). A typical example of a swCNT, together with disordered
graphitic material, is shown in (c). An example of a typical defect mwCNT is shown in (d); a defect in the wall is indicated by an arrow head.
group given OVA alone (Figure 5(a)). The total cell num-
bers were significantly higher in the groups given swCNT,
mwCNT, and ufCBP than in the CNF groups, with the excep-
tion ofCNFCwhich elicited significantly higher cell numbers
than CNFA and CNFD.The particles that increased the total
cell numbers also significantly increased the neutrophil cell
numbers (Figure 5(b)). The eosinophil numbers were low in
the groups treated with OVA alone or together with the CNF
samples. Exposure toOVAwith swCNTormwCNT, however,
induced significantly higher eosinophil numbers than OVA
alone or OVA with any of the CNF samples (Figure 5(c)).
ufCBP with OVA also increased the eosinophil numbers,
although the numbers were only significantly higher than
in mice treated with OVA alone or together with CNF
A and CNF B. The number of lymphocytes was slightly,
but statistically significantly, increased in the swCNT group
only (Figure 5(d)), and the epithelial cell numbers were only
marginally affected (data not shown). swCNT, mwCNT, and
ufCBP with OVA significantly increased the macrophage
numbers compared to OVA alone (Figure 5(e)), while CNF
C was the only CNF sample that significantly increased
the macrophage numbers. The percentage of macrophages
associated with particles did not differ markedly between the
different particle types (Figure 5(f)). However, the CNF D,
swCNT, mwCNT, and ufCBP tended to be associated with
a lower percentage of macrophages than CNF A, B, and C
and were significantly different for swCNT and ufCBP only,
as compared to CNF B.
Due to accidental thawing, only half of the BALF samples
were analyzed for cytokines, reducing the ability to detect
statistically significant differences. The levels of MCP-1 after
OVA booster apparently were increased by all particles with
OVA except CNF B (Figure 5(g)). The tendencies were most
pronounced for CNF A, CNF C, mwCNT, and ufCBP,
although statistical significance was reached only for the
latter. Although the levels of TNF-𝛼 were low at this time
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Figure 3: Allergen-specific antibodies after subcutaneous coinjection of allergen and particles. Serum levels of OVA-specific IgE (a), IgG1
(b), and IgG2a (c) 26 days after subcutaneous injection into one hind footpad of 10 𝜇g OVA alone (white bars) or together with 200 𝜇g
CNF (samples A, B, C, and D; black bars) or ufCBP (light grey bars). On day 21, all mice were boosted with 10 𝜇g OVA in the footpad.
Values (ng or arbitrary units (AU) per mL) for individual mice (circles) and median values (columns) for groups of eight mice are shown. If
values were outside the dynamic range of the ELISA assays, the dotted lines indicate the lower or upper quantitative detection limits for the
assays. Asterisk denotes significant differences compared to the OVA group, ∗∗𝑃 < 0.001, ∗𝑃 < 0.05. Brackets denote statistically significant
differences between the particle groups, 𝑃 < 0.05.
point (23 days after particle exposure), CNF A and ufCBP
with OVA tended to induce higher levels than the other
groups (Figure 5(h)).
4. Discussion
Studies of airway effects of CNF are scarce in the literature. In
the present study, we demonstrate that CNF can promote pro-
duction of allergen-specific IgE after injection and intranasal
exposure to mice. While CNF A and CNF C, and not CNF
B and CNF D, demonstrated IgE adjuvant capacity in the
injection model, all four CNF samples elicited similar levels
of IgE in the airway model. The increase in IgE levels was
not associated with a clear allergic airway inflammation in
the intranasal model used, since no significant eosinophil
influx was observed after allergen booster. Our observation
that CNF promote antibody production is in agreement
with previous studies reporting allergy-promoting activity of
nanosized particles like ultrafine polystyrene particles, ufCBP
and CNT [1, 2, 10, 11, 16].
In the intranasal model, the sw and mw CNT samples
elicited markedly higher IgE levels than the CNF samples,
accompanied with a clear eosinophil airway inflammation.
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Figure 4: Allergen-specific antibodies after intranasal coexposure to allergen and particles. Serum levels of OVA-specific IgE (a), IgG1 (b),
and IgG2a (c) 26 days after intranasal exposure to 10𝜇g OVA alone (white bars) or together with 133𝜇g particles on days 0, 1 and 2 (total dose
of 30𝜇g OVA and 400𝜇g particles).The four samples of CNF (black bars), swCNT andmwCNT (dark grey bars), and ufCBP (light grey bars)
were used. On days 21, 22, and 23, all mice were boosted intranasally with 10 𝜇g OVA (per day). Values (ng or arbitrary units (AU) per mL)
for individual mice (circles) and median values (columns) for groups of ten mice are shown. If values were outside the dynamic range of the
ELISA assays, the dotted lines indicate the lower or upper quantitative detection limits for the assays. Asterisk denotes significant differences
compared to the OVA group, ∗∗𝑃 < 0.001,∗𝑃 < 0.05. # Denotes significant differences compared to all other particle groups, 𝑃 < 0.05.
Brackets denote statistically significant differences between particle groups, 𝑃 < 0.05.
The features of the two CNT samples, making them different
from theCNF samples, are the presence of long, thin, and hol-
low structures (tubes), as opposed to the wider, hat-stacked,
more compact structures of the CNF (Figure 1, Table 2). In
addition, the present CNT are longer and have 1/2–1/20 of
the diameter as compared to the CNF, giving them a higher
aspect ratio (i.e., the length/width ratio). Particles with high
aspect ratios, such as asbestos fibers, have demonstrated high
toxicity, and CNT have been reported to have pathogenic
features similar to asbestos fibers [17].Themain characteristic
distinguishing nanofibers from nanotubes is the stacking of
graphene sheets of varying shapes [18]. While sw and mw
CNT consist of single or multiple graphene sheets rolled into
concentric cylinders, herringbone (hat-stacked) CNF consist
of graphite layers arranged at an angle to the axis of the
filament structure, forming a stacked arrangement of cones
(Figure 2). This intrinsic difference results in less mechanical
strength of CNF compared to CNT [18], as also observed in
our study, since the CNF were more susceptible to breaking
during the sonication process. In contrast to what has been
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Figure 5: Airway inflammationmeasured after intranasal coexposure to allergen and particles. Cell numbers and cytokines in BALF collected
following OVA booster, 26 days after intranasal exposure of mice to allergen alone or together with particles (as described in legend of
Figure 4). The total cell numbers (a) were determined on a Coulter cell counter, whereas the number of neutrophils (b), eosinophils (c),
lymphocytes (d), and macrophages (e) and the percent of particle-associated macrophages (f) were determined by counting 400 cells per
stained cytoslide. The amount of MCP-1 (g) and TNF-𝛾 (h) in BALF supernatants was determined by CBA assay. Values for individual mice
(circles) and group medians (columns) for groups of ten mice are shown, except MCP-1 and TNF-𝛼 where only half of the samples could be
measured. Asterisk denotes significant differences compared to the OVA group, ∗∗𝑃 < 0.001, ∗𝑃 < 0.05. Statistically significant differences
between particle groups are given in the results section.
observed for mwCNT [19], hat-stacked CNF implanted in
subcutaneous tissue of rats appeared to become shorter and
display decreased degree of aggregation over time [20]. The
authors suggested that delamination of graphene layers by
hydrophilic substances or energy from cytoplasmic motion
may be involved in CNF shortening. Thus, although studies
have demonstrated some biodegradation in vitro [21], the
present and previous data suggest that the CNF samples have
lower biopersistence than the CNT samples.
Further, the open, hollow structure of the CNTmay be of
importance for the allergy-promoting capacity, for instance,
as a depot of allergens. Carbon particles have previously
been shown to act as allergen carriers [22, 23], and a depot
effect has been suggested as one mechanism for particle
adjuvant effects [24]. The above mentioned reports support
the present finding that tube-associated characteristics, such
as a thin, hollow tube structure with assumed high bioper-
sistence, appeared to be particularly important features for
the allergy-promoting effect of particles in the airways. CNT
also generate reactive oxygen species [25], which probably
plays an additional role in their induction of airway allergic
inflammation.The capacity of CNF to formROS is unknown.
Knowledge on which particle characteristics are impor-
tant for the different biological effects is a prerequisite to
enable production of less toxic particles [26]. An advantage
of this study was the availability of four CNF batches
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Table 2: Distribution of selected particle characteristics and the allergy-promoting capacity for all particles tested (as measured by high
levels of OVA-specific IgE and eosinophil airway inflammation). To simplify the identification of particle characteristics of importance for
the modulated allergy responses after airway exposure, the levels of each particle property or allergic response are subjectively categorized
into three levels, illustrated by roman, bold italic, or bold font.
Main carbon
structure
Fraction of
fibers/tubes versus
disordered material
Fiber/tube
width (nm)
Surface area
(m2/g)
Structural
defects
(𝑅 = 𝐼D/𝐼G)
Metallic
contaminants
Allergy-promoting
capacity
CNF A Fibers, openchannels Medium
37.01 ± 1.57
[11.25–108.69] 103 1.7
High, mainly
Ni Medium
CNF B
Fibers,
periodically
closed channels
High 83.14 ± 4.18
[18.90–302.21] 61 0.7 Traces Medium
CNF C Fibers, openchannels Low
35.82 ± 2.13
[14.46–185.75] 124 0.9
High, mainly
Ni Medium
CNF D Fibers, periodicallyclosed channels Medium
70.57 ± 2.68
[18.52–286.85] 56 0.6 Traces Medium
swCNT Tubes, openchannels Medium
4.05 ± 0.23
[1.41–10.91 nm] 543 n.a.
High, mainly
Co High
mwCNT Tubes, openchannels High
15.04 ± 0.47
[7.62–29.01 nm] 140 n.a.
Less, mainly
Ni(Fe) High
ufCBP Spherical Not relevant Not relevant 321 1.2 Traces Medium
manufactured in the same facility but with varying particle
characteristics deliberately introduced by changingmanufac-
turing conditions [7]. Despite their qualitative differences,
the allergy-promoting capacity of the four CNF samples did
not differ in the intranasal model, neither with regard to IgE
levels nor eosinophil influx. In the footpad injection model,
on the other hand, only the CNF A and CNF C increased
OVA-specific IgE levels. CNF A and CNF C also tended
to differ from the other CNF samples with regard to other
endpoints, such as higher levels of IgG1 and IgG2a antibodies
in both models and some of the inflammatory markers
in the BALF. Although the biological implications of these
observations are unclear, they indicate that the CNF A and
CNF C samples differ from the CNF B and CNF D samples
with regard to induction of biological responses. Common
for CNF A and CNF C is a higher metal content, about twice
as large relative surface area, a lower mean fiber width, a
higher proportion of open channel fibers, and a tendency
towards a higher number of defective sites compared to CNF
B and CNF D (Table 2). These are all parameters affected
by the high temperature treatment performed to reduce
the metal content in CNF B and CNF D (described in
[7]), and our results therefore suggest that heat-treated CNF
may be less toxic with regard to some biological responses.
Unfortunately, the association between these heat-treatment
sensitive parameters makes it hard to identify single key
properties responsible for the higher responses to the CNF A
and CNF C. Both metal content, surface area, and structural
defects have been suggested to play a role in particle-induced
lung inflammation and allergy-promoting effects in mice [16,
27–32].However, we cannot exclude that the lower fibermean
width and the higher proportion of open channeled fibers
in the CNF A and CNF C samples may have contributed to
the stronger responses to these particles. Indeed, this would
be in agreement with the apparent importance of a thin,
hollow structure on the allergic adjuvant effect, as discussed
previously.
5. Conclusion
The present data demonstrate that CNF and CNT modulate
airway responses to allergens, resulting in allergic airway
inflammation and production of allergen-specific IgE in
mice. When different CNF samples were compared with
swCNT andmwCNT, however, the CNT samples appeared to
be especially potent in promoting allergic responses, possibly
due to their thin, hollow tube structure and assumed high
biopersistence. This study provides a basis for studies aiming
to further identify the particle properties of importance for
airway effects and studies aiming to better understand which
airway mechanisms are underlying the allergy-promoting
effect of nanoparticles such as CNF and CNT.
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